US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on proposed modernization of FDA’s drug review office

FDA has proposed an important series of new steps to modernize the organization and functions of CDER’s Office of New Drugs.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on proposed modernization of FDA’s drug review office